Cell Line Development Market: By Product, By Source, By Type, By Application & By Region - Forecast 2017-2022

  • ID: 4425345
  • Report
  • 137 pages
  • IndustryARC
1 of 3
Cell line construction or Cell line development acts as a key factor in reducing the production costs of biopharmaceuticals while producing a high yield of product. Development and selection of cell lines compatible with production requirements can lead to significant time savings at later stages of biopharmaceuticals production. Rapid growth and technological advancement in pharmaceutical industry is expected to remain key growth driver for cell line development market during the period of study.
This report identifies the global cell line development market size in for the year 2015-2017, and forecast of the same for year 2022. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global cell line development market.

Geographically North America dominated the global cell line development market owing to technological advancement, higher investment in R&D activities by healthcare and pharmaceutical industry. North America was followed by Europe and Asia-Pacific as the second and third largest markets for cell line development. However Asia-Pacific is expected to remain the fastest growing market during the period of study driven by rapidly expanding and increasing presence of global pharmaceutical and healthcare giants in the major economies such as India and China in the region.
This report segments global cell line development market on the basis of product, source, type, application, end user and regional market as follows:
On the basis of products this report on global cell line development market is segmented as follows, covering all major products in the cell line development as follows: Products, Media, Reagents and Sera
This report on global cell line development also covers in detail various sources of cell line development, some of the major sources covered in the report are mammalian, amphibian and insect
This report on global cell line development also covers in detail types of cell line development, some of the major types covered in the report are cloud based, Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines
This report on global cell line development also covers in detail various applications of cell line development, some of the major applications covered in the report are bioproduction, Tissue Engineering & Regenerative Medicine, toxicity Testing, Research, Drug Discovery
This report on cell line development has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample companies profiled in this report are:
GE Healthcare (Division of General Electric Company)
American Type Culture Collection (ATCC)
Corning, Inc.
European Collection of Cell Cultures (ECACC)
Lonza Group AG
30+.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Cell Line Development Market – Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Cell Line Development Market– Forces
4.1. Drivers
4.1.1. Technological advancement in pharmaceutical industry
4.1.2. Rising vaccine production
4.2. Restraints
4.2.1. High capital requirement
4.2.2. Development of stable and authenticate cell line
4.3. Opportunities
4.3.1. Increasing Risk of Pandemics and Communicable Diseases
4.3.2. Low Income Countries to Create Opportunities for the Cell Line Market
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Cell Line Development Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life cycle Analysis
5.5. Suppliers & Distributors

6. Cell Line Development Market, By Product
6.1. Cell Line Development Market, Products
6.1.1. Biosafety Cabinets
6.1.2. Cell Counters & Viability Analysis Systems
6.1.3. Incubators
6.1.4. Centrifuges
6.1.5. Bioreactors
6.1.6. Storage Equipment
6.1.7. Automation Systems
6.1.8. Microscopes
6.1.9. Filtration Systems
6.1.10. Other Equipment
6.2. Cell Line Development Market, Media & Reagents
6.2.1. Sera
6.2.2. Media
6.2.3. Reagents

7. Cell Line Development Market, By Source
7.1. Mammalian
7.2. Insect
7.3. Amphibian

8. Cell Line Development Market, By Type
8.1. Primary Cell Lines
8.2. Continuous Cell Lines
8.3. Hybridomas
8.4. Recombinant Cell Lines

9. Cell Line Development Market, By Application
9.1. Bioproduction
9.2. Tissue Engineering & Regenerative Medicine
9.3. Toxicity Testing
9.4. Research
9.5. Drug Discovery

10. Cell Line Development Market, By Geography
10.1. Europe
10.1.1. Germany
10.1.2. France
10.1.3. Italy
10.1.4. Spain
10.1.5. Russia
10.1.6. U.K.
10.1.7. Rest of Europe
10.2. Asia Pacific
10.2.1. China
10.2.2. India
10.2.3. Japan
10.2.4. South Korea
10.2.5. Rest of Asia-Pacific
10.3. North America
10.3.1. U.S.
10.3.2. Canada
10.3.3. Mexico
10.4. Rest of the World (RoW)
10.4.1. Middle East
10.4.2. South America
10.4.3. Africa

11. Cell Line Development – Market Entropy
11.1. Expansion
11.2. Technological Developments
11.3. Merger & Acquisitions, and Joint Ventures
11.4. Supply- Contract

12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
12.1. American Type Culture Collection (ATCC)
12.2. Corning, Inc.
12.3. European Collection of Cell Cultures (ECACC)
12.4. GE Healthcare
12.5. Lonza Group AG
12.6. Sartorius AG
12.7. Selexis SA
12.8. Sigma-Aldrich Corporation
12.9. Thermo Fisher Scientific, Inc.
12.10. Wuxi Apptec
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibiliography
13.5. Compilation of Expert Insights
13.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll